文献速递心脑血管急症

高敏心肌肌钙蛋白检测导致的诊断重新分类

Diagnostic Reclassification by a High-Sensitivity Cardiac Troponin Assay.
PubMed 文献 · Ann Emerg Med · 2020-08-15
一句话结论与常规cTnI相比,hs-cTnT未显著改变心肌梗死诊断,但使心肌损伤诊断大幅增加(16% vs 0.6%)。

本研究为前瞻性、单中心、前后对照观察性研究,纳入美国急诊科18岁以上接受单次或连续心肌肌钙蛋白检测的患者1016例(男性506例,占50%;中位年龄60岁)。比较常规cTnI与hs-cTnT检测间、以及联合与性别特异性hs-cTnT阈值间的诊断重新分类率,采用第四版心肌梗死通用定义由医师裁定诊断。结果显示,cTnI与hs-cTnT间心肌梗死诊断重新分类仅6例(0.6%,95%CI 0.2%-1.3%),其中心肌损伤诊断重新分类166例(16%,95%CI 14%-19%)。结论认为hs-cTnT与常规cTnI相比对心肌梗死诊断无临床相关变化,但心肌损伤诊断明显增多。

要点

  • 在1016例急诊患者中,常规cTnI与hs-cTnT间心肌梗死诊断重新分类率仅0.6%(95%CI 0.2%-1.3%),6例中5例由心梗重新分类为无心肌梗死。
  • hs-cTnT导致心肌损伤诊断重新分类率16%(95%CI 14%-19%),166例中154例重新分类为存在心肌损伤。
  • 研究采用第四版心肌梗死通用定义由医师裁定诊断,比较常规cTnI与hs-cTnT及联合与性别特异性hs-cTnT阈值。
  • 适用人群为急诊科18岁以上因任何原因接受单次或连续心肌肌钙蛋白检测的成人患者,研究为单中心前后对照设计。
  • 床旁启示:hs-cTnT可能大幅增加心肌损伤诊断,需关注其对后续检查、处置及资源利用的影响。

适用人群与场景

  • 美国急诊科18岁及以上患者,因任何原因接受单次或连续心肌肌钙蛋白检测者,纳入hs-cTnT实施前后的前后对照观察。

诊断标准与关键阈值

  • 采用第四版心肌梗死通用定义由医师裁定诊断。
  • 联合与性别特异性阈值均采用各检测方法已发表的第99百分位参考上限。
  • 诊断重新分类定义为:患者使用一种检测方法诊断为心肌梗死或心肌损伤,而使用另一种检测方法未诊断。

研究设计与关键结果

  • 研究类型:前瞻性、单中心、前后对照观察性研究,纳入1016例患者(男性506例,占50%;中位年龄60岁,25-75百分位49-71岁)。
  • 主要终点:常规cTnI与hs-cTnT间心肌梗死诊断重新分类6例(0.6%,95%CI 0.2%-1.3%),6例中5例重新分类为无心肌梗死。
  • 心肌损伤诊断重新分类166例(16%,95%CI 14%-19%),166例中154例重新分类为存在心肌损伤。
  • 同时比较了联合与性别特异性hs-cTnT阈值间的诊断重新分类,采用各检测方法已发表的第99百分位参考上限。

证据类型、等级与局限

  • 证据类型:前瞻性、单中心、前后对照观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 与常规cTnI相比,hs-cTnT检测在心肌梗死诊断上无临床相关变化,但心肌损伤诊断明显增多(16% vs 0.6%),可能影响急诊后续检查与处置。
  • 作者认为hs-cTnT与常规cTnI相比心肌梗死诊断无临床相关变化,但心肌损伤诊断大幅增加。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Our objective is to describe the rates of diagnostic reclassification between conventional cardiac troponin I (cTnI) and high-sensitivity cardiac troponin T (hs-cTnT) and between combined and sex-specific hs-cTnT thresholds in adult emergency department (ED) patients in the United States.

METHODS: We conducted a prospective, single-center, before-and-after, observational study of ED patients aged 18 years or older undergoing single or serial cardiac troponin testing in the ED for any reason before and after hs-cTnT implementation. Conventional cTnI and hs-cTnT results were obtained from a laboratory quality assurance database. Combined and sex-specific thresholds were the published 99th percentile upper reference limits for each assay. Cases underwent physician adjudication using the Fourth Universal Definition of Myocardial Infarction. Diagnostic reclassification occurred when a patient received a diagnosis of myocardial infarction or myocardial injury with one assay but not the other assay. Our primary outcome was diagnostic reclassification between the conventional cTnI and hs-cTnT assays. Diagnostic reclassification probabilities were assessed with sample proportions and 95% confidence intervals for binomial data.

RESULTS: We studied 1,016 patients (506 men [50%]; median age 60 years [25th, 75th percentiles 49, 71]). Between the conventional cTnI and hs-cTnT assays, 6 patients (0.6%; 95% confidence interval 0.2% to 1.3%) underwent diagnostic reclassification regarding myocardial infarction (5/6 reclassified as no myocardial infarction) and 166 patients (16%; 95% confidence interval 14% to 19%) underwent diagnostic reclassification regarding myocardial injury (154/166 reclassified as having myocardial injury) by hs-cTnT.

CONCLUSION: Compared with conventional cTnI, the hs-cTnT assay resulted in no clinically relevant change in myocardial infarction diagnoses but substantially more myocardial injury diagnoses.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Mumma BE, Casey SD, Dang RK, et al. Diagnostic Reclassification by a High-Sensitivity Cardiac Troponin Assay. Ann Emerg Med. 2020. PMID: 32807538. doi:10.1016/j.annemergmed.2020.06.047

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。